Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Valeant Pharmaceuticals International Inc. > News item |
Valeant to redeem Salix’s 6% senior notes due 2021 in two stages
New York, April 1 – Valeant Pharmaceuticals International, Inc. said its subsidiary Salix Pharmaceuticals, Ltd. will redeem all $750 million of its 6% senior notes due 2021.
The redemption will have two parts: $262.5 million of the debt will be repaid on May 1 while the remaining $487.5 million will be redeemed on May 4, according to a news release.
Valeant announced Wednesday that it had completed its acquisition of Salix.
Valeant is a Laval, Quebec-based specialty pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.